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We describe the use of the recently developed number and brightnessmethod (N&B) that uses confocal images tomonitor aggre-
gation of Huntingtin exon 1 protein (Httex1p) directly in living cells. N&Bmeasures the molecular brightness of protein aggregates
in the entire cell noninvasively based on intensity ﬂuctuations at each pixel in an image. N&B applied to mutant Httex1p in living
cells showed a two-step pathway leading to inclusion formation that is polyQ length dependent and involves four phases. An initial
phase of monomer accumulation is followed by formation of small oligomers (5–15 proteins); as protein concentration increases,
an inclusion is seeded and forms in the cytoplasm; the growing inclusion recruits most of the Httex1p and depletes the cell leaving
only a low concentration of monomers. The behavior of Httex1p in COS-7 and ST14A cells is compared.INTRODUCTIONHuntington’s disease (HD) is one of nine known inherited
neurodegenerative diseases caused by an expansion of a pol-
yglutamine (polyQ) stretch beyond a threshold of ~40 gluta-
mines in the affected protein (1). This expansion leads to
formation of the large protein inclusions typical of this
disease (1). Observations, including those indicating that
naked polyQ peptides alone can cause degeneration, have
led to the hypothesis that aggregation of expanded polyQ
domain peptides initiates the disease (2–6). Several studies
in cell-free systems (7–9) find that synthetic polyQ peptides
in solution can undergo a nucleated add-on growth polymer-
ization mechanism with direct formation of amyloid-like
aggregates (10). Other observations suggest that, in different
conditions, synthetic peptides can adopt different conforma-
tional and aggregation states including oligomers, protofi-
brils and amyloid fibrils (11,12). Recent studies suggest
that polyQ, in the presence of amino acids N1–17 of Hun-
tingtin (Htt), can undergo a novel and complex mechanism
of aggregation in a cell-free setting (13). Takahashi et al.
(14) observed polyQ oligomerization in cell lysates by fluo-
rescence correlation spectroscopy (FCS), measuring the
change in the diffusion time of the aggregates. FCS can
show information about the size, number, and diffusion
time of fluorescent particles but it is restricted to a single
point measurement. Despite these many studies, the mecha-
nism of aggregation that leads to the formation of inclusions
in live cells is controversial. A method to follow the events
leading to protein aggregation in living cells and tissues
would help advance our understanding of the aggregation
process.Submitted January 7, 2010, and accepted for publication February 12, 2010.
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0006-3495/10/06/3078/8 $2.00We use the number and brightness (N&B) method devel-
oped recently to explore the aggregation dynamics of the
pathogenic Httex1p peptide in cells. N&B measures the fluo-
rescence fluctuation at each pixel in the image as a function
of time thus allowing localization and quantification of the
average size of protein aggregates (15,16). Conventional
microscopy can detect the formation of the inclusion but
cannot determine the distribution and size of intermediate
protein aggregates.
From our results, we derived a model for Httex1p aggre-
gation in cells. We find that Httex1p with expanded polyQ
aggregates by a dynamic two-step mechanism of monomers
forming oligomers and finally inclusions. The process
involves four phases where monomers accumulate to
a threshold concentration (Phase 1) at which point, they
begin to form small oligomers (Phase 2) until a second
threshold is reached that results in a nucleation event (Phase
3) that is followed by a rapid recruitment of Httex1p into
large inclusions (Phase 4). We find that oligomers are in
equilibrium with monomers both in the nucleus and the cyto-
plasm, and that a fibrillar intermediate is not an obligate step
to inclusion formation. As the inclusion forms, it becomes
insoluble and sequesters the majority of the Httex1p in the
cell.METHODS
Cell culture
COS-7 (African green monkey kidney) cells were grown in D-MEM high
glucose medium (Invitrogen, Carlsbad, CA) containing 10% heat inactivated
fetal bovine serum (Invitrogen), 1% penicillin/streptomycin, 0.5% Hepes
1 M at 37C in 5% CO2. ST14A cells are derived from primary cells disso-
ciated from embryonic day 14 rat striatal primordial tissue (17). This cell line
is grown in D-MEM high glucose containing 10% heat inactivated fetal
bovine serum, 110 mg/L sodium pyruvate, 4.5 g/L D-glucose, L-glutamine,doi: 10.1016/j.bpj.2010.02.058
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chosen as a model of the aggregation mechanism because it originates in
a tissue most impacted by HD in animals and humans. Transfections are
carried out using Lipofectamine 2000 (Invitrogen) in accordance with manu-
facturer’s protocol. Cells were transfected with Httex1p containing plasmids
bearing varying lengths of polyglutamine fused at the C-terminus to EGFP
(Httex1p 97QP-EGFP, Httex1p 46QP-EGFP, and Httex1p 25QP-EGFP)
(18). Monomeric EGFP transfected cells were used to calibrate the bright-
ness scale. Cells were plated on 35-mm glass bottom dishes (MatTek, Ash-
land, MA) for imaging. Extensive previous studies have shown that the
specific constructs with EGFP used in our studies produce the phenotypes
characteristic of the HD disease (19).Microscopy
Images were acquired with an Olympus FluoView1000 confocal laser scan-
ning microscope using an excitation wavelength of 488 nm and an UP-
LSAPO 60-1.2 NA water objective. Laser power was set at 0.8%
corresponding to ~2 mW at the sample. During imaging, cells were in an
incubator at 37C and 5% CO2 (INU; Tokai-Hit, Shizuoka-ken, Japan).
Images were acquired at different times (from 20 to 50 h after transfection).
For the N&B analysis, we acquired a stack of 100 frames for each field. The
size of the images was 256  256 pixels. The acquisition time was 20 ms/
pixel. The stack of 100 images was acquired in ~2 min. We acquired images
of the cell of interest every 20 min for several hours. Several cells (~20) were
chosen in each preparation.N&B analysis
The N&B fluctuation analysis allows the quantification and localization of
aggregates by the brightness map (15). N&B distinguishes pixels with
many dim molecules from pixels with few bright molecules in an image
because the degree of aggregation of fluorescent molecules is related to
the average and variance of the intensity distribution. For a given average,
the larger the variance, the fewer molecules contribute to the average. The
apparent number of particles (N) and apparent brightness (B) are related to
the average (hki) and variance (s2) of the intensity distribution in any given
pixel by the following expressions (Eqs. 1 and 2) where the average is calcu-








The average intensity is proportional to the product of the number of parti-
cles, n, in the volume of excitation and molecular brightness 3. The variance
arises from two contributions. One is due to the fluctuation of numbers of
particles in the pixel and the other is due to the detector shot noise. Equations






3 þ 1n; (3)
B ¼ s
2
hki ¼ 3 þ 1: (4)
Immobile molecules have apparent brightness B equal to 1, because there is
no variance due to particle fluctuations other than the shot noise. The bright-
ness (B) of the immobile fraction, 1, is independent of the laser power,
whereas B of the mobile fraction is laser power-dependent. By changingthe laser power it is possible to distinguish the immobile from the mobile
fraction. This characteristic is important in the interpretation of the data.
We determined that the large inclusions are immobile. With N&B, when
a given pixel contains a mixture of species with different levels of bright-
ness, the N&B method averages the brightness; thus, working with low
concentrations provides more resolving power. The correction of the molec-
ular brightness for the immobile fraction and the number of molecules are
given by Eqs. 5 and 6.
3m ¼ 3
1 þ R; (5)
nm ¼ nð1 þ RÞ þ Iimð1 þ RÞ
3
; (6)
where R is the intensity ratio between the immobile and mobile fractions at 1
pixel.
We set the Olympus FluoView 1000 to the pseudo-photon counting mode
of data acquisition (16). In this mode, the parameters needed for N&B anal-
ysis are the detector offset, the factor S that converts photon counts to digital
levels and the readout variance s0
2. In the case of an analog detector, the
N&B equations become Eqs. 7 and 8:




3 þ 1n; (7)
B ¼ s
2  s20
hki  offset ¼ Sð3 þ 1Þ: (8)
For the analysis of this work, the values of these parameters were calibrated
according to the principles described in (16). We obtained S ¼ 2, s02 ¼ 0,
and offset ¼ 0.
N&B is based on fluctuation analysis. Therefore, the pixel dwell time is an
important parameter. It should be faster than the decay time of the fluctua-
tions. If the dwell time is longer than the time a particle takes to cross the
excitation volume, the variance is reduced and the particles appear to be
more numerous and less bright. Usually, for molecules in solution,
a maximum pixel dwell time of 4 ms is needed, whereas for measurements
of proteins in cells, a maximum pixel dwell time between 20 and 32 ms is
sufficient (15). Photobleaching and cell movements increase the variance,
and thus the apparent brightness. To correct for these processes, we applied
a high pass filter algorithm (detrend filter) to the time sequence at each pixel
of the stack. The filter algorithm eliminates the trend due to photobleaching
and slow cell movements and restores the average intensity at each pixel.
The high pass filter maintains the fluctuations due to changes in particle
number in one pixel if the particle fluctuations are faster than the changes
due to photobleaching and/or motion (15).
We used the brightness map to determine the size of aggregates at a given
location. The brightness histogram gives information on the overall distribu-
tion of aggregates sizes. The N&B analysis was implemented in the SimFCS
software (www.lfd.uci.edu). Under the hypothesis that the quantum yield
does not change during aggregation, B can be used to extract the number
of fluorescent molecules in the aggregate according to Eq. 4. If there is
quenching of the monomer fluorescence due to aggregation, the N&B anal-
ysis will underestimate the aggregate size.Calibration with mEGFP
To calibrate the laser power and scanning conditions required for the
measurement of monomeric EGFP, we measured the brightness of COS-7
cells transiently expressing nonaggregating mEGFP. These conditions
were then used for the Httex1p-EGFP experiments. We measured the bright-
ness (B) of COS-7 cells transiently expressing monomeric EGFP at the sameBiophysical Journal 98(12) 3078–3085
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ments. We determined the aggregate size using the expression (Eq. 9) (15)
AggregateSize ¼ Baggregate  1
Bmonomer  1: (9)
B  1 has units of counts per molecule per pixel dwell time. To convert to
counts/molecules/s (cpms), we divided B  1 by the pixel dwell time in
seconds, tpixel (Eq. 10)
Counts=s=Molecule ¼ ðB 1Þ
tpixel
: (10)
The measurements with cells expressing monomeric EGFP were carried out
at the beginning and at the end of each experiment to confirm the stability of
the instrument. The N&B analysis is laser power-dependent, so the power
was rigorously kept constant for all the experiments. The apparent brightness
of monomeric EGFP is determined by selecting the center of the Gaussian
distribution of the pixel brightness histogram in an image of a cell trans-
fected with monomeric EGFP (Fig. 1). In the B histogram (Fig. 1 C), only
a few pixels are outside the distribution centered at B¼ 1.074 corresponding
to brightness of 3700 cpsm.RESULTS
HD is associated with an expansion of a polyQ tract in the
protein coding region (near the N-terminus of Htt). Extensive
evidence shows that processed N-terminal peptide (Httex1p)
fragments of Htt with a polyQ expansion are found in path-
ologic specimens from HD patients and can cause disease in
model organisms including flies, worms, mice, and other
organisms (20–25). Evidence also exists that processed frag-
ments containing the polyQ stretch are associated with
disease in other triplet repeat disorders (26). Accordingly,
we have tagged human exon 1 fragments containing different
polyQ lengths with EGFP (Httex1p-25QP-EGFP, Httex1p-
46QP-EGFP, and Httex1p-97QP-EGFP). COS-7 and ST14A
were transfected with Httex1p-EGFP. Only cells with a low
protein expression level at the commencement of the exper-
iment were chosen for time lapse imaging so that the entire
evolution of monomers to aggregates could be monitored
and measured. These cells were then followed for 3–4 h.
For each condition R20 cells were characterized.Calibration of molecular brightness of monomeric
EGFP
To determine the monomeric molecular brightness, COS-7
cells were transfected with monomeric EGFP. The intensity
map for a single plane that transects the nucleus shows
a widespread distribution throughout the cytoplasm and
nucleus (Fig. 1). The brightness histogram shows the pres-
ence of a single distribution of brightness (Fig. 1 C). Pixels
in this distribution account for all the fluorescence in the
cell. In this case, monomers are located in all cellular
compartments (Fig. 1 B, green). The brightness value ob-
tained is 1.074 corresponding to 3700 cpms (counts/mole-
cule/s) for monomeric EGFP.Biophysical Journal 98(12) 3078–3085Unexpanded Httex1p remains monomeric
(Httex1p-25QP-EGFP)
Unexpanded Httex1p typically does not form inclusions but
whether it transiently forms oligomeric species in live cells is
not known. COS-7 cells were transiently transfected with un-
expanded Httex1p-25QP-EGFP and observed for several
hours starting 51 h after transfection (Fig. 2). The majority
of the protein is in the monomeric form (Fig. 2 B) and
remains monomeric for the duration of the experiment
with a modest preference for cytoplasmic localization
(Fig. 2 A). This can be observed in the brightness (B) histo-
gram, where the curve of the monomers (green line) selects
most of the pixels of the cell (Fig. 2, B and C). When the
images of these cells were filtered to show species corre-
sponding to oligomers no evidence of transient oligomeriza-
tion was found despite the fact that some cells achieve a very
high concentration of soluble monomer. The few pixels
(<6% of all the pixels representing the cell) with B R
1.74 are clustered on the membranes where their movement
will be coherent if the membrane moves thus leading to an
apparent brightness value greater than monomer.Expanded polyQ Htt forms oligomers (Httex1p-
46QP-EGFP)
COS-7 cells transfected with Httex1p-46QP-EGFP were fol-
lowed for several hours starting 46 h after transfection. Early
during the observation period, the brightness histogram re-
vealed a uniform distribution of monomers throughout the
cell. As overall EGFP signal intensity increased, monomers
accumulated to the point where the number map indicated
a cellular concentration >1 mM, at which point particles of
increased brightness were detected indicating that higher
order complexes were forming (Fig. 3, C and D, first row).
The brighter particles representing oligomers were centered
on a single average aggregate size equivalent to 10 5 5
monomers at a density representing ~12% of the total
number of pixels defined by the cell and preferentially
located close to the membrane in the periphery of the cell
(Fig. 3 C). Large inclusion formation was not seen in the
cells chosen for observation during the ~4 h of observation.
Pixels exhibiting monomer brightness were found in ~88%
of the total pixels representing the cell. The accumulation
of the oligomeric particles reached a plateau indicating equi-
librium with the monomers.
In cells transfected with Httex1p-46QP-EGFP, many
bright fluorescent vesicles and membrane movements were
present. Vesicles are easily identified because of their slow
motion compared with the oligomers. Membrane move-
ments are localized at the borders of the cell and can be sepa-
rated from the fast motion of the oligomers in the cell
interior. The slow movements of membrane or organelle
bound fluorescent particles can bias brightness calculations
because they are source of large variance. To determine
FIGURE 1 Determination of molecular bright-
ness. A COS-7 cell transiently transfected with
mEGFP is shown. (A) Average intensity image of
a single optical plane with excitation at 488 nm at
0.8% laser power and 20 ms/pixel. (B) Selection of
pixels whose brightness corresponds to monomers,
B ¼ 1.074 indicates that monomers are distributed
uniformly throughout the cell. (C) Brightness histo-
gram. Selection of pixels corresponding to the
Gaussian distribution centered at B ¼1.074 cpm,
(3 ¼ 3700 cpsm) identifies the monomeric protein.
Only a few pixels are outside the distribution of
the monomeric brightness. These pixels tend to
concentrate at the cell border or at the border of
internal membranes. This analysis depicts the
N&B map of a uniform, monomeric EGFP species.
Huntingtin Aggregation in Cells 3081the proportion of the large brightness signature (e.g., of
B > ~1.5) that was due to membrane and/or organelle bound
particles rather than to small inclusions at specific sites in the
cell, we compared the brightness map obtained with and
without the detrend filter (see Methods) that computationally
removes the contributions due to slow-moving features asso-
ciated with large cellular structures such as membranes or
mitochondria. The images in Fig. 3, top row, were processed
using the detrend filter. This comparison shows that a large
number of particles are slow moving and is consistent with
observations that a significant fraction of Httex1p interacts
with membranes (13).Increasing the polyQ length results in inclusions
formation (Httex1p-97QP-EGFP)
To assess the behavior of longer polyQ-containing peptides,
COS-7 cells transfected with Httex1p-97QP-EGFP were fol-
lowed. As for the expanded 46 polyQ construct, we observed
a first phase of accumulation of monomers. Different cells
exhibited different rates of EGFP accumulation and oligo-
merization, and inclusion formation was observed at
different times after transfection. These differences however,
correlate with the EGFP intensity of the cells suggesting that
the aggregation process does not depend on the time after
transfection but on protein concentration in the cell. We
used brightness analysis to determine when oligomers ap-
peared (Fig. 4). As with the 46QP peptides, oligomerization
does not appear until the monomer concentration exceeds
1 mM. At that point, monomers aggregate into oligomerscontaining on average 10 5 5 Httex1p-97QP-EGFP mole-
cules as determined by the apparent molecular brightness.
As more protein is expressed and the total concentration of
protein increases by a factor of 1.5 to 2, determined from
the number analysis, a nucleation site for the inclusion is
formed in the cytoplasm (Fig. 4, green arrow). The inclusion
grows in intensity and size, reaching a maximum in ~30 min
to 1 h (Fig. 4, red arrow). The inclusion recruits almost all
the Httex1p-97QP-EGFP protein in the cell, shown in the
intensity image at 56 h. At this point, the protein concentra-
tion is depleted to a range of ~0.1 mM, well below the
threshold level needed to form oligomers. The inclusion
recruits protein from both the nucleus as well as the cyto-
plasm indicating that nuclear Httex1p-97QP-EGFP is in
dynamic equilibrium with the cytoplasmic compartment.
After formation of the inclusion, the brightness at the inclu-
sion decreased to B ¼ 1, indicating that the inclusion is
immobile (see Methods). The histograms of the percentage
of pixels in the monomer and oligomer conformation
(Fig. 4) corresponding to the different phases of aggregation
show the evolution of the distribution of aggregate sizes from
the formation of the first oligomers to the formation of the
inclusion body. The percentage of pixels with brightness
values corresponding to oligomers (B > 1.4) increases until
the inclusion forms (Fig. 4; yellow bar in the histogram).
Because the remaining soluble protein after the inclusion is
formed is monomeric, oligomers must be in equilibrium
with monomers to rapidly (in minutes) leave the nucleus
and be recruited by the inclusion. We never observed very
large oligomeric species (>20 proteins), indicating absenceFIGURE 2 COS-7 cell transiently transfected
with Httex1p-25QP-EGFP. Cells were imaged
51 h after transfection with 0.8% laser power at
488 nm and 20 ms/pixel. (A) Intensity image of
a single plane shows widespread presence of
Httex1p-25QP-EGFP, slightly lower levels in the
nucleus. (B) Selection of the pixels with brightness
corresponding to the monomers (B ¼ 1.074,
3 ¼ 3700 cpsm). (C) Pixel brightness histogram
confirms the prevalence of monomers.
Biophysical Journal 98(12) 3078–3085
FIGURE 3 COS-7 cell transfected with Httex1p-
46QP-EGFP. Cells were imaged with 0.8% laser
power at 488 nm and 20 ms/pixel. (A) Average
intensity image reveals widespread distribution.
(B) Selection of the pixels with brightness corre-
sponding to monomers (B ¼ 1.074, 3 ¼ 3700
cpsm) detrended (first row) and without the detrend
filter (second row). Monomers are distributed
throughout the cell. (C) Selection of the pixels
with brightness corresponding to oligomers
(centered on decamer, B ¼ 1.74, 3 ¼ 37,000
cpsm) detrended (first row) and not detrended
(second row). (D) Brightness histogram with the
distribution of the pixel after detrend (first row)
and before detrend (second row). The fraction of
higher brightness pixels has increased with respect
to the histogram of D. In the case of not detrended
data, the values of B recovered are larger because of
the fluctuation due to the cell motion.
3082 Ossato et al.of nanofibrillar structures as a separate species that would
appear as bright spots in the cell.Aggregation dynamics of Httex1p-polyQ-EGFP in
ST14A cells
Httex1p aggregation was also measured in ST14A cells
(Fig. 5), to determine if the mechanism of aggregation
seen in COS-7 cells is similar in neuronal precursor cells.
ST14A cells were transfected with mEGFP to calibrate the
monomer brightness value; the monomeric brightness ob-
tained for COS-7 and ST14A was the same (3700 cpms).
Cells transfected with Httex1p-25QP-EGFP and Httex1p-Biophysical Journal 98(12) 3078–308546QP-EGFP constructs showed the same behavior observed
in the COS-7 cells (data not shown). Similar to COS-7 cells,
ST14A cells expressing Httex1p-97QP-EGFP initially
formed oligomers of the same size range and at the same
concentration threshold as the COS-7 cells followed by the
formation of inclusions. Like the COS-7 cells, recruitment
of proteins from the nucleus to the inclusion was also
observed in ST14A cells. The nucleation event also starts
at a localized spot in the cell (Fig. 5, green arrow). The over-
all aggregation process (monomer-oligomer-inclusion) was
slower in these cells compared to COS-7 cells (35 h vs.
24 h). This could be attributed to lower expression levels
and/or the lower culture temperature (33C vs. 37C). InFIGURE 4 Time evolution of COS-7 cell trans-
fected with Httex1p-97QP-EGFP. Cells were
imaged with 0.8% laser power at 488 nm and
20 ms/pixel. The different rows correspond to the
different phases. The first column shows the
average intensity image. The molecular brightness
first increases and then decreases after the forma-
tion of the inclusions (red arrows). The green
arrows indicate the points of nucleation. The selec-
tion of pixels with the brightness of the monomers
(B ¼ 1.074, 3 ¼ 3700 cpsm) and oligomers
(B ¼ 1.74, 3 ¼ 37,000 cpsm) are reported in the
second and third columns. In the fourth column
the percentage of pixels corresponding to monomer
(green) and oligomers (yellow) are reported, this
graph has been obtained from the analysis of
different cells at the different phases shown. The
number of pixels with brightness corresponding to
decamers increases until the inclusion is formed
and recruits the majority of the protein.
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sites was larger than in COS-7 cells (Fig. 5).FIGURE 5 Time evolution of ST14A cell transiently transfected with
Httex1p-97QP-EGFP, cells were imaged with 0.8% laser power at 488 nm
and 20 ms/pixel. (First column) Intensity image, the green arrow indicates
a nucleation point; red arrows indicate the inclusions. (Second column)
Selection of pixels with the brightness of the monomers (B ¼ 1.074,
3 ¼ 3700 cpsm). (Third column) Selection of oligomers (centered on deca-
mer, B ¼ 1.74, 3 ¼ 37,000 cpsm). In the fourth column the percentage of
pixels with brightness corresponding to monomer (green) and oligomer
(yellow) in different cells in the four phases are reported. The percentage
of oligomers increases until the inclusion is formed and recruits the majority
of the protein.
FIGURE 6 Model of Httex1p-97QP-EGFP aggregation. Phase 1, initial
expression of Httex1p. The protein concentration is low (<1 mM), only
monomers are detected. Phase 2, at higher protein concentration (~1 mM
of monomers), small oligomers (5–15 proteins) form in a process that lasts
few hours. Phase 3, inclusions start to grow at each nucleation site. Phase 4,
the inclusions recruit most of the protein present in the cell leaving only
monomers at low concentration.DISCUSSION
On the basis of the N&B analysis, we propose a model for
Httex1p aggregation in live cells (Fig. 6). In this model the
aggregation of Httex1p-polyQ occurs in four phases.
1. In the first phase (accumulation phase) there is expression
of Httex1p beginning at a low protein concentration and
accumulating (<1 mM). During this period there are
only monomers in the cell.
2. In the oligomer phase, monomers reach a threshold
concentration (>1 mM), and small oligomer (~10 5 5
proteins) formation begins in a process that lasts ~2 h.
Monomers and oligomers are in a rapid equilibrium and
accumulate to a total concentration of ~1.5 to 2 mM. Olig-
omerization occurs when Httex1p has polyQ tracts of 46
Qs or longer.
3. In the third phase (nucleation phase) one (or more) nucle-
ation sites leading to large inclusions are observed in
cytoplasm.
4. In this phase, most of the protein present in the cell is re-
cruited by the inclusion leaving only monomers at
a depleted concentration.
This study shows a dynamic biphasic process of aggregation
of mutant Httex1p with an expanded polyQ domain. We find
that monomers, after achieving a cellular concentration
of ~1 mM, form oligomers. A number of factors can
influence the estimate of oligomer size from the brightness
fluctuation including a subset of immobile species or nonflu-
orescent Httex1p molecules such as endogenous protein (that
is low in COS-7 cells (27)) or nonmatured EGFP molecules
(it is estimated that ~10–20% of EGFP proteins never reach
maturation to become fluorescence competent (28)). All of
these factors can result in an underestimation of the oligomer
size. The brightness histogram shows that the distribution
width does not extend more than two to three times the
average value, even if the average is underestimated thus al-
lowing one to conclude that the oligomer size is not >155 5
monomers. We observe pixels with lower brightness than
monomer preferentially located around the nucleus (data
not shown). We interpreted this result as due to partially im-
mobilized proteins in this region (Eqs. 5 and 6). For the rest
of the cell, the brightness is relatively constant.
The process of protein aggregation in diseases such as HD
has been the subject of intense study. Some studies have sug-
gested that large inclusions are pathogenic (3) whereas others
suggest that they are protective (19,29–31) and that interme-
diate oligomers are the pathogenic species (32). A number of
studies have investigated the possible diversity of other olig-
omeric conformations of Htt with expanded polyQ using cell
free systems. Using conformation specific antibodies and/or
electron or atomic force microscopy, investigators have beenable to detect a number of higher order structures such as
various fibrils and amyloid like structures e.g., Tanaka
(ex1) (13,33). A similar spectrum of aggregation intermedi-
ates and morphologies have been observed for many types of
amyloids, such as a synuclein (34), islet amyloid (35), and
nondisease-associated neoamyloids (36).Biophysical Journal 98(12) 3078–3085
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meric forms. We find a relatively homogeneous distribution
of oligomer sizes; thus, if multiple oligomeric species with
different conformations are forming in this system, they
are all apparently within the 5–15 particle size range.
Further, we find no evidence for nanofibrils. A fibril would
be readily detected in this method. Fibrils and amyloid struc-
tures will appear in the brightness histogram, unless they are
immobile and if they are immobile, they will not rapidly
disappear when the inclusion is formed. As none of these
was observed, we conclude that the pathway to inclusion
formation in living cells may involve a simpler two
conformer process with monomers proceeding to oligomers
that later give way to inclusions. Fibrils have been found in
electron microscopy studies associated with inclusions but
not as individual species (4).
There are several indications that the cellular environment
affects the aggregation process. For example, the rate of
inclusion maturation in this study was significantly different
COS-7 versus ST14A cells, with the rate of growth of the
inclusion after nucleation site varying from 30 min to 1 h.
Another notable difference between cell types is in the
number of inclusions formed, whereas in COS-7 cells few
(max 2) big inclusions are formed, in ST14A cells, we
observed more (~10) smaller inclusions. We propose that
the number of inclusions is related to the number of nucle-
ation centers formed per unit time and the rate of inclusion
growth. If the rate of nucleation sites formed is slow or the
rate of inclusion growth is rapid, the first inclusion formed
will recruit all proteins in the cell before other inclusions
can form. The parameters affecting these behaviors remain
to be determined but may include proteins such as the
poly(Q)-binding peptide, QBP1, that inhibits poly(Q)-
EGFP oligomer formation in vitro (14) or proteins that foster
monomer stability (38). Unlike studies with inducible pC12
cells (39), we have not observed inclusions forming in
the cell nucleus. This may reflect a distinct propensity of
pC12 cells for nuclear seeding. Our experiments show that
oligomer formation occurs only in cells that accumulate
a sufficiently high monomer concentration (in the 1 mM
range). We find that monomers and oligomers are in rapid
equilibrium, which differs from studies of Httex1p-polyQ
in solution in which fibrils and amyloid structures were
observed (13). This difference suggests that protein aggrega-
tion process could be affected by the presence of other
proteins, enzymes, organelles, and structures in the cells
that are not found in the cell free environment of these
studies.
N&B shows the process of aggregation in real-time.
A distinctive advantage of this method is that aggregation
is studied directly in the entire living cell. Therefore the
Httex1 protein can interact with organelles, lipids, and other
proteins in the cell. With this method, it is possible to
observe the distribution of a protein under physiological
conditions, and the time evolution of the aggregation processBiophysical Journal 98(12) 3078–3085as the protein is expressed in the cell. Other techniques in
fluorescence fluctuation analysis can measure molecular
brightness (for example photon counting histogram analysis)
but they do not provide information on the spatial distribu-
tion of the aggregates (40).
The protein oligomerization we observe in live cells agrees
with previous studies using FCS on cell lysates that showed
the oligomerization of simple polyQ peptides fused to
EGFP (14). The behavior of Httex1p revealed by these studies
provides a basis for understanding how inclusions may be
protective (19). If oligomers are indeed a toxic species, the
formation of large inclusions causes a rapid depletion of
monomer concentration to a level below the threshold for
oligomerization; thus protecting the cell from toxic oligomer
formation. Further, although fibrils have been observed in
other conditions and appear to follow a nucleation – add on
mechanism (41), we find that fibril formation is not an obli-
gate step for the formation of inclusions.
The specific fragment we have used has the EGFP
construct. It is possible that the EFGP moiety could perturb
the species formed in the cell environment. Although this is
a possibility, we found that it is the length of the polyQ
sequence that determines aggregation rather than the pres-
ence of the EFGP. Also studies with a transgenic animal
model carrying the EGFP moiety show that the characteristic
symptoms of HD are retained (42).
The N&B method is a powerful approach to study cellular
processes involving aggregation of proteins such as receptor
dimerization. This technique is not limited to intracellular
processes; it can be applied to study the formation of extra-
cellular aggregates typical of other neurodegenerative
diseases (e.g., Alzheimer disease).
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